title: A rare unilateral case of ocular mucous membrane pemphigoid.
abstract: OBJECTIVE
  Ocular mucous membrane pemphigoid (MMP) is known to be rapidly progressive in younger patients and affects both eyes. We are aware of only one other reported case of unilateral ocular MMP. The case presented in this study is unique in that it demonstrates genuinely unilateral ocular MMP in a younger patient.
  
  
  METHODS
  We report a case of a 50-year-old man who presented with a 3-month history of left eye redness, irritation, and mild discharge. He also suffered from mouth ulcers, skin lesions, and recurrent nose bleeds secondary to nasal mucosal lesions.
  
  
  RESULTS
  Examination revealed unilateral lid granulomas and cicatricial conjunctivitis in his left eye. There were no abnormal findings in his right eye. Biopsy of the lesions showed nonspecific inflammation with positive immunofluorescence for immunoglobulin G and C3 on epithelial basement membranes of conjunctiva, buccal mucosa, and skin, which were consistent with MMP. He was treated with immunosuppression and had no disease progression at 12-month follow-up.
  
  
  CONCLUSIONS
  This represents a rare case of unilateral nonprogressive ocular MMP in a younger patient. Histological analysis and immunofluorescence testing excluded a neoplastic process and confirmed the diagnosis. This case demonstrates that the presentation of unilateral eyelid pyogenic granulomas should include ocular MMP in the differential diagnosis once a neoplastic process has been excluded.
authors.affiliation: The Save Sight Institute, The University of Sydney and The Sydney Eye Hospital, Sydney, Australia.
authors.forename: Athena
authors.initials: A
authors.lastname: Roufas
authors.forename: Peter
authors.initials: P
authors.lastname: Kim
authors.forename: Dianne
authors.initials: D
authors.lastname: Reeves
authors.forename: Gerard
authors.initials: G
authors.lastname: Sutton
mesh_terms: D001706:Biopsy; D003176:Complement C3 / Q000276:immunology; D003231:Conjunctivitis / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D004359:Drug Therapy, Combination; D004844:Epistaxis / Q000175:diagnosis; D005141:Eyelid Diseases / Q000175:diagnosis; D019084:Fluorescent Antibody Technique, Indirect; D006099:Granuloma / Q000175:diagnosis; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D019226:Oral Ulcer / Q000175:diagnosis; D010390:Pemphigoid, Benign Mucous Membrane / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D003176:Complement C3; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D011241:Prednisone; D008727:Methotrexate